Deep01, a developer of artificial intelligence (AI) software designed to help physicians interpret computerized tomography (CT) images of the brain, has raised US$2.7 million in financing, with Asustek Computer leading the round of fundraising.
"Deep01 is a leading startup in Asia focused on AI medical solutions, and we look forward to harnessing the strength of this collaboration to further develop applications in the field of smart medical technology," said Albert Chang, Asustek corporate VP and co-head of the AIoT Business Group.
The round also saw investment from Digital Economy Fund co-funded by ITRI (Industrial Technology Research Institute) and III (Institute for Information Industry), and BE Capital.
Jim Li, managing partner of Digital Economy Fund, noted that Deep01 has obtained FDA clearances from both the US and Taiwan.
Arthur Chen, managing director of BE Capital said, "Deep01 is a member of the BE supporting program. The system is in the Show Chwan hospital, and profitable results are already present. The AI emergency network has potential in the overseas markets. We introduced the company to the authorities in Japan, and the integration will proceed in the second half of this year."
The ICT and healthcare industries in Taiwan are competitive on the international stage, and successful cases of commercialization will make our product more feasible in the global market, said David Chou, founder and CEO of Deep01.
Deep01 said its AI product can detect acute intracerebral hemorrhage (ICH) in the A&E department. With an accuracy of 93-95% and 30 seconds per case, the performance exceeds the other competitors in the market, it calimed, adding that Deep01 is the first AI company in APAC to obtain US-FDA clearances in July 2019.
Deep01 said it also won Taiwan's FDA clearance for its AI product of ICH in February 2020 and received its first purchase order of US$0.7 million. The AI-based service has launched in two medical centers and four local hospitals in Taiwan.
Deep01 said its next step is to expand into global markets and to offer more AI-based services to the department of A&E, radiology, and neurosurgery.
Asustek corporate VP Albert Chang (left) and Deep01 CEO David Chou